comparemela.com

Latest Breaking News On - Stem cell transplantation - Page 15 : comparemela.com

Army Hospital Successfully Conducts First Ever Life-saving Bone Marrow Transplant On 7-year-old

The procedure aimed to replace the defective immune cells with healthy ones, offering a renewed chance at a healthy and vibrant life. - Army Hospital Successfully Conducts First Ever Life-saving Bone Marrow Transplant On 7-year-old

Delhi cantonmentPradip paudelRajiv kumarGen ajith nilakantanSanjeev kheraSushant paudelArmy hospitalIndian army does itHematology department brig rajan kapoorIndian armyDepartment of hematologyHematology departmentArmy hospital research and referralBone marrow transplantArmy does it againStem cell transplantation

This Frontline Therapy Is Better in Multiple Myeloma: Study

A study directly comparing real-world outcomes suggests patients with transplant-ineligible multiple myeloma do better with frontline triple therapy with daratumumab vs bortezomib.

United statesDorisk hansenAmerican society of hematologyNational comprehensive cancer networkMoffitt cancer center research institute in tampaMoffitt cancer centerResearch instituteAmerican societyMultiple myelomaPlasma cell myelomaMonoclonal antibodyBiologic therapyProteasome inhibitorTransplantation of stem cellsRansplantation of hematopoietic stem cellsHematopoietic stem cell transplant

Dr Jain on the Importance of Novel Therapies in Pediatric Patients With Bleeding Disorders

Akshat Jain, MBBS, discusses the importance of novel therapies in the treatment of pediatric patients with beleeding disorders.

Akshat jainLoma linda university school of medicineDepartment of pediatricsSchool of public healthHematology oncology divisionSickle cell disease program for childrenInherited bleeding disorderSickle cell disease programYoung adultsStem cell transplantationClinical medicineOncology divisionPublic healthLoma linda university schoolAsh annual meeting and expositionOnclive tv

No Benefit to Salvage Transplant in R/R Multiple Myeloma

Long-term follow-up shows no progression-free or overall survival advantage among patients who received salvage transplant vs continuous lenalidomide plus dexamethasone.

Salt lake cityUnited statesBaden wübergUniversity of utahManni mohyuddinMarc andrea baertschUniversity hospital heidelbergGerman cancer research centerAmerican society of hematologyAmerican societyMultiple myelomaPlasma cell myelomaBiologic therapyTransplantation of stem cellsRansplantation of hematopoietic stem cellsHematopoietic stem cell transplant

Sickle Cell: Good Outcomes for Haploidentical Transplants

It is much easier to find eligible haploidentical donors half-matched or partially matched than eligible hematopoietic donors.

United statesVanderbilt universityMayo clinic in rochesterAdetolaa kassimLansky karnofskyAsmaa ferdjallahBlood instituteVanderbilt university medical centerNational heartNational cancer instituteAmerican society of hematologyMarrow transplant clinical trials networkAmerican societyMayo clinicSickle cell diseaseIckle cell anemia sickle anaemia

vimarsana © 2020. All Rights Reserved.